| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Motility | 8 | 2023 | 92 | 2.480 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2020 | 59 | 1.370 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 3 | 2020 | 26 | 1.210 |
Why?
|
| Electric Stimulation | 4 | 2017 | 426 | 1.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2020 | 1130 | 1.070 |
Why?
|
| Parasympathetic Nervous System | 1 | 2023 | 26 | 0.900 |
Why?
|
| Obesity | 5 | 2017 | 2884 | 0.780 |
Why?
|
| Peptide Hydrolases | 5 | 2014 | 256 | 0.780 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 116 | 0.760 |
Why?
|
| Gastric Emptying | 3 | 2013 | 94 | 0.730 |
Why?
|
| Cell Hypoxia | 5 | 2009 | 328 | 0.720 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2020 | 854 | 0.700 |
Why?
|
| Autonomic Pathways | 1 | 2019 | 3 | 0.690 |
Why?
|
| Smad3 Protein | 1 | 2020 | 129 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 2 | 2009 | 45 | 0.680 |
Why?
|
| Spinal Nerves | 1 | 2019 | 45 | 0.670 |
Why?
|
| Sacrum | 1 | 2019 | 132 | 0.640 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 224 | 0.620 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 224 | 0.620 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 2027 | 0.590 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 84 | 0.570 |
Why?
|
| Nucleoproteins | 1 | 2016 | 37 | 0.550 |
Why?
|
| Blood Glucose | 1 | 2019 | 1244 | 0.510 |
Why?
|
| Satiation | 2 | 2013 | 27 | 0.490 |
Why?
|
| Ubiquitination | 10 | 2020 | 575 | 0.460 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 287 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 1362 | 0.460 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2018 | 600 | 0.440 |
Why?
|
| Insulin Resistance | 1 | 2017 | 731 | 0.400 |
Why?
|
| Postprandial Period | 2 | 2010 | 85 | 0.400 |
Why?
|
| Energy Intake | 1 | 2013 | 515 | 0.390 |
Why?
|
| Rats | 4 | 2020 | 6086 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 810 | 0.360 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2020 | 2359 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 1439 | 0.330 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1026 | 0.320 |
Why?
|
| Postoperative Period | 2 | 2020 | 665 | 0.300 |
Why?
|
| Up-Regulation | 5 | 2020 | 2450 | 0.300 |
Why?
|
| Muscle Contraction | 1 | 2007 | 218 | 0.290 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 236 | 0.290 |
Why?
|
| Animals | 21 | 2020 | 59536 | 0.280 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 4557 | 0.280 |
Why?
|
| 14-3-3 Proteins | 3 | 2011 | 143 | 0.270 |
Why?
|
| Glucose | 5 | 2011 | 1248 | 0.270 |
Why?
|
| Biomarkers, Tumor | 4 | 2019 | 10331 | 0.270 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 324 | 0.260 |
Why?
|
| Multiprotein Complexes | 3 | 2012 | 395 | 0.260 |
Why?
|
| Viscera | 1 | 2005 | 81 | 0.250 |
Why?
|
| Intestines | 1 | 2009 | 686 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1077 | 0.250 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 589 | 0.250 |
Why?
|
| Intestine, Small | 1 | 2007 | 499 | 0.240 |
Why?
|
| Vagus Nerve | 2 | 2020 | 63 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 2063 | 0.230 |
Why?
|
| COP9 Signalosome Complex | 5 | 2014 | 72 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2009 | 376 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2014 | 8873 | 0.220 |
Why?
|
| Transcription Factors | 6 | 2005 | 5270 | 0.210 |
Why?
|
| Hypoxia | 4 | 2005 | 443 | 0.200 |
Why?
|
| Exonucleases | 2 | 2011 | 51 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 7 | 2011 | 5061 | 0.190 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 51 | 0.190 |
Why?
|
| Cell Line, Tumor | 10 | 2020 | 14551 | 0.190 |
Why?
|
| Neoplasms | 5 | 2016 | 15193 | 0.190 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 78 | 0.180 |
Why?
|
| Smad2 Protein | 1 | 2020 | 89 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2020 | 292 | 0.180 |
Why?
|
| Smad Proteins | 1 | 2020 | 88 | 0.180 |
Why?
|
| Oleanolic Acid | 1 | 2020 | 108 | 0.180 |
Why?
|
| Electrodes, Implanted | 2 | 2013 | 183 | 0.170 |
Why?
|
| Spectrin | 1 | 2020 | 85 | 0.170 |
Why?
|
| Humidity | 1 | 2019 | 29 | 0.170 |
Why?
|
| Mice, SCID | 5 | 2009 | 1869 | 0.170 |
Why?
|
| Humans | 35 | 2020 | 261506 | 0.160 |
Why?
|
| Electromyography | 1 | 2019 | 226 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2012 | 507 | 0.160 |
Why?
|
| Acupuncture Analgesia | 1 | 2017 | 2 | 0.160 |
Why?
|
| Mutation | 2 | 2016 | 15179 | 0.150 |
Why?
|
| Mice | 13 | 2020 | 34495 | 0.150 |
Why?
|
| Heterografts | 1 | 2020 | 733 | 0.150 |
Why?
|
| Body Weight | 2 | 2017 | 1293 | 0.150 |
Why?
|
| Gastrectomy | 1 | 2020 | 451 | 0.150 |
Why?
|
| Temperature | 1 | 2019 | 506 | 0.150 |
Why?
|
| Gene Silencing | 1 | 2020 | 837 | 0.150 |
Why?
|
| Genomics | 2 | 2019 | 2738 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2012 | 3552 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2010 | 1082 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2020 | 2074 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2011 | 5178 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2020 | 4804 | 0.130 |
Why?
|
| Craniotomy | 1 | 2017 | 304 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2020 | 2803 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 673 | 0.130 |
Why?
|
| Mice, Nude | 3 | 2020 | 4307 | 0.130 |
Why?
|
| Protein Binding | 4 | 2016 | 3438 | 0.130 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 42 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2020 | 1442 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 703 | 0.120 |
Why?
|
| Multigene Family | 1 | 2016 | 425 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 2216 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 803 | 0.120 |
Why?
|
| Anesthesia | 1 | 2017 | 296 | 0.120 |
Why?
|
| Flow Cytometry | 4 | 2011 | 3033 | 0.120 |
Why?
|
| Nuclear Proteins | 4 | 2016 | 3343 | 0.110 |
Why?
|
| Stem Cells | 1 | 2020 | 1213 | 0.110 |
Why?
|
| Metformin | 2 | 2014 | 378 | 0.110 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 1048 | 0.110 |
Why?
|
| Male | 9 | 2020 | 123000 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2020 | 7226 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2013 | 2203 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 4143 | 0.100 |
Why?
|
| Dendritic Cells | 3 | 2007 | 1085 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 1443 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2017 | 1819 | 0.100 |
Why?
|
| Signal Transduction | 6 | 2019 | 11965 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 750 | 0.100 |
Why?
|
| Electrodiagnosis | 1 | 2010 | 19 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 3154 | 0.090 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 2054 | 0.090 |
Why?
|
| Organophosphates | 1 | 2010 | 41 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 4053 | 0.090 |
Why?
|
| Cell Division | 3 | 2003 | 2489 | 0.090 |
Why?
|
| Sirolimus | 1 | 2014 | 814 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 5 | 2003 | 5395 | 0.090 |
Why?
|
| Dyspepsia | 1 | 2010 | 103 | 0.090 |
Why?
|
| Diet | 1 | 2017 | 1440 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 260 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2330 | 0.080 |
Why?
|
| DNA Damage | 3 | 2012 | 1954 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 2864 | 0.080 |
Why?
|
| Mechanoreceptors | 1 | 2008 | 28 | 0.080 |
Why?
|
| Histones | 1 | 2016 | 1466 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 5159 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 7222 | 0.080 |
Why?
|
| Adrenomedullin | 2 | 2006 | 104 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2007 | 43 | 0.080 |
Why?
|
| Apoptosis | 5 | 2011 | 7591 | 0.080 |
Why?
|
| Aurora Kinases | 3 | 2012 | 189 | 0.080 |
Why?
|
| Female | 10 | 2020 | 141928 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 143 | 0.070 |
Why?
|
| Transfection | 4 | 2010 | 2944 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 1062 | 0.070 |
Why?
|
| Antineoplastic Agents | 4 | 2014 | 14289 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2086 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 586 | 0.070 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2005 | 57 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1467 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2018 | 5542 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2019 | 3341 | 0.070 |
Why?
|
| Dogs | 1 | 2007 | 1155 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2009 | 1643 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 1859 | 0.070 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2005 | 1 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2003 | 682 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2003 | 331 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2004 | 34 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 443 | 0.060 |
Why?
|
| Quinazolines | 1 | 2010 | 923 | 0.060 |
Why?
|
| Tretinoin | 1 | 2007 | 623 | 0.060 |
Why?
|
| Sensation | 1 | 2005 | 71 | 0.060 |
Why?
|
| Selectins | 1 | 2004 | 6 | 0.060 |
Why?
|
| Laminin | 1 | 2004 | 194 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2004 | 138 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2004 | 68 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 1 | 2004 | 74 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2004 | 217 | 0.060 |
Why?
|
| Young Adult | 2 | 2013 | 21445 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2009 | 3536 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 866 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 360 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 2003 | 115 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2012 | 2518 | 0.050 |
Why?
|
| Reference Values | 1 | 2005 | 1099 | 0.050 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2002 | 24 | 0.050 |
Why?
|
| Middle Aged | 4 | 2020 | 86204 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Cisplatin | 1 | 2009 | 2432 | 0.050 |
Why?
|
| Linear Models | 1 | 2005 | 1085 | 0.050 |
Why?
|
| Adult | 4 | 2020 | 77950 | 0.050 |
Why?
|
| Biological Transport | 1 | 2003 | 597 | 0.050 |
Why?
|
| Cell Movement | 2 | 2007 | 2466 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 577 | 0.050 |
Why?
|
| Aurora Kinase B | 2 | 2012 | 68 | 0.050 |
Why?
|
| Exoribonucleases | 2 | 2011 | 42 | 0.050 |
Why?
|
| HCT116 Cells | 2 | 2012 | 348 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 4821 | 0.050 |
Why?
|
| Breast Neoplasms | 4 | 2014 | 15694 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 33 | 0.050 |
Why?
|
| RNA, Messenger | 6 | 2007 | 6150 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6100 | 0.050 |
Why?
|
| Neutrophils | 1 | 2004 | 835 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 3639 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 2049 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2010 | 1008 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 159 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 3 | 2005 | 55 | 0.040 |
Why?
|
| Mitosis | 2 | 2012 | 615 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 323 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 7548 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 2693 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 2927 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 1271 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 1479 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2007 | 2967 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 4971 | 0.030 |
Why?
|
| Time Factors | 1 | 2010 | 12926 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 1547 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2014 | 12873 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 1248 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 70117 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4757 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 96 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2010 | 1620 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2004 | 259 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2007 | 5637 | 0.030 |
Why?
|
| Adolescent | 1 | 2013 | 31252 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 5114 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 3203 | 0.030 |
Why?
|
| Postmenopause | 1 | 2014 | 378 | 0.030 |
Why?
|
| Child | 1 | 2013 | 29154 | 0.030 |
Why?
|
| Interphase | 1 | 2012 | 145 | 0.030 |
Why?
|
| Adipocytes | 1 | 2014 | 305 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 201 | 0.030 |
Why?
|
| Everolimus | 1 | 2014 | 415 | 0.030 |
Why?
|
| Protein Stability | 1 | 2012 | 370 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2012 | 274 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2012 | 344 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 342 | 0.020 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2001 | 1724 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 370 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 148 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2010 | 231 | 0.020 |
Why?
|
| Polyploidy | 1 | 2010 | 73 | 0.020 |
Why?
|
| G2 Phase | 1 | 2010 | 206 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 886 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8865 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2011 | 355 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2010 | 369 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 652 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2010 | 3821 | 0.020 |
Why?
|
| Receptors, CCR7 | 1 | 2007 | 39 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1313 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1546 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 114 | 0.020 |
Why?
|
| Curcumin | 1 | 2008 | 117 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 589 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 4233 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 164 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2005 | 58 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 66 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 1353 | 0.020 |
Why?
|
| Muscles | 1 | 2006 | 416 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 1454 | 0.020 |
Why?
|
| Chemokine CCL4 | 1 | 2004 | 63 | 0.020 |
Why?
|
| Syndecan-4 | 1 | 2004 | 5 | 0.020 |
Why?
|
| Integrin alpha5 | 1 | 2004 | 15 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2004 | 109 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2004 | 157 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 213 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6207 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 7789 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 360 | 0.020 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2004 | 123 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 1399 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2004 | 110 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 445 | 0.010 |
Why?
|
| Receptors, Autocrine Motility Factor | 1 | 2002 | 1 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 621 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2002 | 53 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1390 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 413 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2001 | 11 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 798 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2001 | 61 | 0.010 |
Why?
|
| Monocytes | 1 | 2005 | 788 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 48 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 995 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 176 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 1489 | 0.010 |
Why?
|
| Collagen | 1 | 2004 | 752 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 598 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 874 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1879 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 4917 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 5112 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 1073 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 1664 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 754 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 3101 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 4078 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 6942 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 2488 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 2508 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 3045 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 5047 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3230 | 0.010 |
Why?
|